Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 1CNS 1Breast 1

Conditions

Keratosis, Actinic 1Glioblastoma 1Breast Neoplasms 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1198Oxaliplatin 1160Capecitabine 1142Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interventional × Imipramine × Clear all
NCT04863950 2025-08-27

Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma

The University of Texas Health Science Center at San Antonio

Phase 2 Recruiting
25 enrolled
CNS

Glioblastoma

NCT05688904 2024-04-24

The Effect of Topical Imipramine on Pain and Effectiveness of Topical Photodynamic Therapy

Wright State University

Phase 1 Recruiting
24 enrolled
Dermatologic

Keratosis, Actinic

NCT03122444 2023-06-28

Imipramine on ER+ve and Triple Negative Breast Cancer

The University of Texas Health Science Center at San Antonio

Phase EARLY_PHASE1 Completed
17 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡